Article ; Online: Preventive cardiology for the aging population: how can we better design clinical trials of statins?
Expert review of cardiovascular therapy
2024 Volume 22, Issue 1-3, Page(s) 13–18
Abstract: Introduction: Older adults form a fast-increasing proportion of the world population. However, gains in increasing quantity of life have not been accompanied by similar gains in quality of life. Older people frequently experience frailty, memory ... ...
| Abstract | Introduction: Older adults form a fast-increasing proportion of the world population. However, gains in increasing quantity of life have not been accompanied by similar gains in quality of life. Older people frequently experience frailty, memory problems, and chronic diseases including cardiovascular disease (CVD) and neurodegenerative diseases. Recent trials have demonstrated the efficacy of anti-hypertensive therapy in older populations but failed to show benefits for aspirin. Area covered: Statins clearly reduce CVD events in middle-aged populations. There seems to be evidence that the effect is similar in primary prevention older populations based on meta-analyses mainly from sub-groups in large trials, but this becomes less clear with increasing age. However, given differences in drug metabolism and possibly efficacy, competing co-morbidities, their effects on mortality, disability, and dementia in this age group remain to be determined. Expert opinion: Two large trials are now underway to clarify the role of statin therapy in people aged over 70 years using endpoints of mortality, disability, and neurocognitive endpoints as well as standard cardiovascular disease outcomes. They may provide also provide more evidence on how to approach the over 80 year age group. |
|---|---|
| MeSH term(s) | Aged ; Aged, 80 and over ; Humans ; Middle Aged ; Aging ; Cardiology ; Cardiovascular Diseases/prevention & control ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Primary Prevention ; Quality of Life ; Clinical Trials as Topic |
| Chemical Substances | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| Language | English |
| Publishing date | 2024-01-23 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 2192343-7 |
| ISSN | 1744-8344 ; 1477-9072 |
| ISSN (online) | 1744-8344 |
| ISSN | 1477-9072 |
| DOI | 10.1080/14779072.2024.2302122 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6107: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.